Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) — Strategic Asset Allocation Index
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) has a Strategic Asset Allocation Index of 251.1% as of June 2023. Strategic assets (PP&E of $459.11 Million plus long-term investments of $-) total $459.11 Million, measured against net assets of $182.87 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. For live market cap and overall valuation, see AMRX market cap.
SAAI
Strategic Assets
PP&E
Net Assets
Amneal Pharmaceuticals, Inc. Class A Common Stock Strategic Asset Allocation Index (2018–2022)
This chart shows how Amneal Pharmaceuticals, Inc. Class A Common Stock's Strategic Asset Allocation Index has evolved across 5 annual periods from 2018 to 2022. As of June 2023, the index stands at 251.1%, representing strategic assets of $459.11 Million against net assets of $182.87 Million USD. See how leveraged is Amneal Pharmaceuticals, Inc. Class A Com's balance sheet to measure how much of total assets are equity-financed.
Annual Strategic Asset Allocation Index for Amneal Pharmaceuticals, Inc. Class A Common Stock (2018–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Amneal Pharmaceuticals, Inc. Class A Common Stock from 2018 to 2022, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. Also explore Amneal Pharmaceuticals, Inc. Class A Com annual equity growth to track the company's year-over-year net asset growth rate.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 224.9% | $469.81 Million | $469.81 Million | $- | $208.93 Million | ▲ +84.8 pp |
| 2021 | 140.1% | $514.16 Million | $514.16 Million | $- | $366.97 Million | ▲ +6.2 pp |
| 2020 | 133.9% | $477.75 Million | $477.75 Million | $- | $356.74 Million | ▼ -49.8 pp |
| 2019 | 183.7% | $636.97 Million | $620.60 Million | $16.37 Million | $346.79 Million | ▲ +123.0 pp |
| 2018 | 60.7% | $544.15 Million | $544.15 Million | $- | $896.36 Million | — |